Table 2:

National (not including the territories) distribution of Clostridium difficile strain types among adults diagnosed with health care–associated C. difficile infection from 2009 to 2015*

NAP strainYear; no. (%) of patientsp valueTrend
2009
n = 379
2010
n = 352
2011
n = 384
2012
n = 388
2013
n = 412
2014
n = 385
2015
n = 390
NAP1178 (47.0)173 (49.1)142 (37.0)149 (38.4)148 (35.9)110 (28.6)111 (28.5)< 0.001
NAP248 (12.7)16 (4.5)12 (3.1)14 (3.6)7 (1.7)5 (1.3)11 (2.8)< 0.001
NAP30 (0.0)1 (0.3)0 (0.0)0 (0.0)1 (0.2)2 (0.5)0 (0.0)Not tested
NAP433 (8.7)39 (11.1)66 (17.2)44 (11.3)60 (14.6)69 (17.9)72 (18.5)< 0.001
NAP51 (0.3)1 (0.3)1 (0.3)0 (0.0)1 (0.2)1 (0.3)0 (0.0)Not tested
NAP614 (3.7)10 (2.8)17 (4.4)22 (5.7)17 (4.1)18 (4.7)26 (6.7)0.03
NAP72 (0.5)12 (3.4)6 (1.6)6 (1.5)12 (2.9)11 (2.9)9 (2.3)Not tested
NAP85 (1.3)1 (0.3)4 (1.0)0 (0.0)1 (0.2)1 (0.3)1 (0.3)Not tested
NAP91 (0.3)3 (0.9)0 (0.0)1 (0.3)3 (0.7)2 (0.5)4 (1.0)Not tested
NAP109 (2.4)8 (2.3)16 (4.2)22 (5.7)19 (4.6)11 (2.9)14 (3.6)Not tested
NAP114 (1.1)6 (1.7)16 (4.2)23 (5.9)21 (5.1)52 (13.5)36 (9.2)< 0.001
NAP125 (1.3)7 (2.0)14 (3.6)13 (3.4)10 (2.4)13 (3.4)9 (2.3)Not tested
  • * About 20%–27% of strain types were unassigned and are not shown.

  • p value from tests for significant change in trend over time from 2009 to 2015; results with small samples sizes were not tested for significance.

  • Symbols ↓ or ↑ indicate a significant change (decrease or increase).